BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26337765)

  • 1. Somatic mutations associated with MRI-derived volumetric features in glioblastoma.
    Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ
    Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
    BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
    Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
    Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.
    Henker C; Kriesen T; Fürst K; Goody D; Glass Ä; Pützer BM; Piek J
    J Neurooncol; 2016 Feb; 126(3):585-92. PubMed ID: 26603163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
    Tang C; Guo J; Chen H; Yao CJ; Zhuang DX; Wang Y; Tang WJ; Ren G; Yao Y; Wu JS; Mao Y; Zhou LF
    Int J Clin Exp Pathol; 2015; 8(5):5327-35. PubMed ID: 26191234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death.
    Colen RR; Wang J; Singh SK; Gutman DA; Zinn PO
    Radiology; 2015 Apr; 275(1):215-27. PubMed ID: 25490189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.
    Ivanidze J; Lum M; Pisapia D; Magge R; Ramakrishna R; Kovanlikaya I; Fine HA; Chiang GC
    J Neuroimaging; 2019 May; 29(3):357-363. PubMed ID: 30644143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
    Nicolasjilwan M; Hu Y; Yan C; Meerzaman D; Holder CA; Gutman D; Jain R; Colen R; Rubin DL; Zinn PO; Hwang SN; Raghavan P; Hammoud DA; Scarpace LM; Mikkelsen T; Chen J; Gevaert O; Buetow K; Freymann J; Kirby J; Flanders AE; Wintermark M;
    J Neuroradiol; 2015 Jul; 42(4):212-21. PubMed ID: 24997477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
    Chaddad A; Desrosiers C; Hassan L; Tanougast C
    Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
    Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
    Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
    Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
    J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
    Rao A; Rao G; Gutman DA; Flanders AE; Hwang SN; Rubin DL; Colen RR; Zinn PO; Jain R; Wintermark M; Kirby JS; Jaffe CC; Freymann J;
    J Neurosurg; 2016 Apr; 124(4):1008-17. PubMed ID: 26473782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
    Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
    Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.
    Pichler J; Pachinger C; Pelz M; Kleiser R
    Eur J Radiol; 2013 May; 82(5):e240-5. PubMed ID: 23399039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.
    Ersoy TF; Keil VC; Hadizadeh DR; Gielen GH; Fimmers R; Waha A; Heidenreich B; Kumar R; Schild HH; Simon M
    Neuroradiology; 2017 Dec; 59(12):1223-1231. PubMed ID: 28894890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Baxter LC; Gaw N; Ranjbar S; Plasencia J; Dueck AC; Peng S; Smith KA; Nakaji P; Karis JP; Quarles CC; Wu T; Loftus JC; Jenkins RB; Sicotte H; Kollmeyer TM; O'Neill BP; Elmquist W; Hoxworth JM; Frakes D; Sarkaria J; Swanson KR; Tran NL; Li J; Mitchell JR
    Neuro Oncol; 2017 Jan; 19(1):128-137. PubMed ID: 27502248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
    Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
    Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.